Long noncoding RNA HITT coordinates with RGS2 to inhibit PD-L1 translation in T cell immunity

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• Programmed cell death ligand 1 (PD-L1) is an immune checkpoint protein that promotes cancer immune evasion.
• Understanding PD-L1 regulation is crucial for developing strategies to boost antitumor immunity.
• Translational regulation of PD-L1 remains largely uncharacterized.

Purpose of the Study:

• To investigate the translational regulation of PD-L1.
• To identify novel regulators of PD-L1 expression.
• To explore the therapeutic potential of targeting PD-L1 regulation in cancer immunotherapy.

Main Methods:

• Investigated the role of a long noncoding RNA (lncRNA), HITT, in PD-L1 regulation.
• Examined the interaction of HITT with regulator of G protein signaling 2 (RGS2) and the 5' untranslated region (UTR) of PD-L1.
• Assessed the impact of HITT expression on T cell-mediated cytotoxicity in vitro and in vivo.
• Analyzed clinical correlation of HITT, RGS2, and PD-L1 expression in breast cancer tissues.

Main Results:

• Discovered that HITT is transactivated by E2F1 under IFN-γ stimulation.
• Demonstrated that HITT, in coordination with RGS2, binds to the PD-L1 5' UTR, reducing PD-L1 translation.
• Showed that HITT expression enhances T cell-mediated cytotoxicity in a PD-L1-dependent manner.
• Observed a clinical correlation between HITT/PD-L1 and RGS2/PD-L1 expression in breast cancer.

Conclusions:

• HITT plays a significant role in regulating PD-L1 translation and enhancing antitumor T cell immunity.
• HITT acts as a novel suppressor of PD-L1 expression.
• Activation of HITT presents a potential therapeutic strategy for improving cancer immunotherapy outcomes.